Naltrexone, in low doses such as 3mg to 4.5mg, has been found to boost the immune system in MS, autoimmune diseases, and central nervous system disorders. Naltrexone was FDA-approved in 1985 for the management of alcohol dependence and opioid dependence at 50mg doses.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 222 |
|
|
|
|
|
63 |
| Other | 33 |
|
|
|
11 | ||
| Fatigue | 24 |
|
|
|
|
11 | |
| Stiffness/Spasticity | 14 |
|
|
|
3 | ||
| Mobility | 13 |
|
|
|
5 | ||
| Bladder problems | 10 |
|
1 |
See all 309 patients currently taking Naltrexone
Mouse over the table for more information
Top 10 dosages based on patients currently taking Naltrexone. See all 23 dosages ►
| 3.5 mg all the time (24/7) | daily | 0.4 mg daily | 1 daily | 1 mg daily | 1.5 mcg daily | 1.5 mg daily | 1.5 mL daily | 1.75 mg daily | 2 mg daily | 2 mL daily | 4.5 mg | 2.5 mg daily | 3 mg daily | 3.5 mg daily | 4 mg daily | 4.25 mg daily | 4.5 mg daily | 5 mg daily | 6 mg daily | 9 mg daily | 50 mg daily | 380 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
6
|
1
|
1
|
3
|
1
|
11
|
1
|
1
|
4
|
1
|
1
|
1
|
74
|
12
|
11
|
1
|
170
|
3
|
1
|
1
|
3
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
25 | 46% |
|
|
Other
|
13 | 24% |
|
|
Side effects too severe
|
12 | 22% |
|
|
Doctor's advice
|
8 | 15% |
|
|
Personal research
|
3 | 6% |
|
|
Expense
|
3 | 6% |
|
|
Course of treatment ended
|
2 | 4% |
|
|
Not indicated
|
2 | 4% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.